Brief: Neovacs Unveils 80 Million Euro Investment Program For Coming Years

Neovacs SA

06/09/2021 07:19

Sept 6 (Reuters) - Neovacs SA  ALNEV.PA :
    * UNVEILS 80 MILLION EUR INVESTMENT PROGRAM FOR THE COMING
YEARS
    * CASH FLOW MAY BE EXTENDED TO A MAXIMUM OF AN ADDITIONAL €
50
MILLION OVER THE NEXT 48 MONTHS IN THE EVENT OF FULL USE OF THE
NEW FINANCING LINE SIGNED ON SEPTEMBER 5, 2021
    * € 58 MILLION TO FINANCE PHASE I AND II CLINICAL TRIALS IN
THE
FIELD OF ALLERGIES
    * € 8 MILLION TO FINANCE NEW INTERNAL RESEARCH AND
DEVELOPMENT
PROGRAMS
    * € 1.3 MILLION IN THE DEVELOPMENT OF A BIOTECH SPECIALIZED
IN
INFECTIOUS DISEASES
    * € 4.2 MILLION IN THE START-UP OF A COVID-19 SCREENING
COMPANY
    * € 8.9 MILLION INVESTMENT IN A REAL ESTATE ASSET CARRYING
ALL THE
PROJECTS

Source text for Eikon:  ID:nNDL1QWTLg 
Further company coverage:  ALNEV.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))